SAN FRANCISCO Aug. 4 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the second quarter ended June 30 2011. Cash cash equivalents and investments at June 30 2011 were $481.8 million as compared to $315.9 million at...
↧